Evidence map›Paper›PMID 38855615›Full record

ArticleExploration (Beijing, China)2024

Scalability of nanopore osmotic energy conversion.

Makusu Tsutsui, Wei-Lun Hsu, Kazumichi Yokota, Iat Wai Leong, Hirofumi Daiguji, Tomoji Kawai

Abstract read
In one paragraph

Article in Exploration (Beijing, China), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Scalability of nanopore osmotic energy conversion.Exploration (Beijing, China) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Makusu TsutsuiThe Institute of Scientific and Industrial Research Osaka University Ibaraki Osaka Japan.
Wei-Lun HsuDepartment of Mechanical Engineering The University of Tokyo Bunkyo-ku Tokyo Japan.
Kazumichi YokotaHealth and Medical Research Institute National Institute of Advanced Industrial Science and Technology (AIST) Takamatsu Kagawa Japan.
Iat Wai LeongThe Institute of Scientific and Industrial Research Osaka University Ibaraki Osaka Japan.
Hirofumi DaigujiDepartment of Mechanical Engineering The University of Tokyo Bunkyo-ku Tokyo Japan.
Tomoji KawaiThe Institute of Scientific and Industrial Research Osaka University Ibaraki Osaka Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial nanofluidic networks are emerging systems for blue energy conversion that leverages surface charge-derived permselectivity to induce voltage from diffusive ion transport under salinity difference. Here the pivotal significance of electrostatic inter-channel couplings in multi-nanopore membranes, which impose constraints on porosity and subsequently influence the generation of large osmotic power outputs, is illustrated. Constructive interference is observed between two 20 nm nanopores of 30 nm spacing that renders enhanced permselectivity to osmotic power output via the recovered electroneutrality. On contrary, the interference is revealed as destructive in two-dimensional arrays causing significant deteriorations of the ion selectivity even for the nanopores sparsely distributed at an order of magnitude larger spacing than the Dukhin length. Most importantly, a scaling law is provided for deducing the maximal membrane area and porosity to avoid the selectivity loss via the inter-pore electrostatic coupling. As the electric crosstalk is inevitable in any fluidic network, the present findings can be a useful guide to design nanoporous membranes for scalable osmotic power generations.

Indexed as

interpore interactionsion selectivitymultiporeosmotic powerreverse electrodialysis

Identifiers

PMID38855615
PMCPMC11022616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.